DK62592D0 - - Google Patents

Info

Publication number
DK62592D0
DK62592D0 DK92625A DK62592A DK62592D0 DK 62592 D0 DK62592 D0 DK 62592D0 DK 92625 A DK92625 A DK 92625A DK 62592 A DK62592 A DK 62592A DK 62592 D0 DK62592 D0 DK 62592D0
Authority
DK
Denmark
Application number
DK92625A
Other languages
Danish (da)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK92625A priority Critical patent/DK62592D0/da
Publication of DK62592D0 publication Critical patent/DK62592D0/da
Priority to IL105672A priority patent/IL105672A0/xx
Priority to PCT/DK1993/000157 priority patent/WO1993023417A1/en
Priority to AU40611/93A priority patent/AU657415B2/en
Priority to EP93909821A priority patent/EP0607367A1/en
Priority to NZ252109A priority patent/NZ252109A/en
Priority to JP5519786A priority patent/JPH06508854A/ja
Priority to CA002113546A priority patent/CA2113546A1/en
Priority to US08/061,892 priority patent/US5430027A/en
Priority to FI940166A priority patent/FI940166A0/fi
Priority to NO940122A priority patent/NO940122L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK92625A 1992-05-14 1992-05-14 DK62592D0 (zh)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DK92625A DK62592D0 (zh) 1992-05-14 1992-05-14
IL105672A IL105672A0 (en) 1992-05-14 1993-05-11 Substituted adenosine derivatives and pharmaceutical compositions containing them
CA002113546A CA2113546A1 (en) 1992-05-14 1993-05-12 Novel adenosine derivatives
EP93909821A EP0607367A1 (en) 1992-05-14 1993-05-12 Novel adenosine derivatives
AU40611/93A AU657415B2 (en) 1992-05-14 1993-05-12 Novel adenosine derivatives
PCT/DK1993/000157 WO1993023417A1 (en) 1992-05-14 1993-05-12 Novel adenosine derivatives
NZ252109A NZ252109A (en) 1992-05-14 1993-05-12 Adenosine derivatives and pharmaceutical compositions
JP5519786A JPH06508854A (ja) 1992-05-14 1993-05-12 新規のアデノシン誘導体
US08/061,892 US5430027A (en) 1992-05-14 1993-05-14 2-chloro-N6 -substituted adenosines, their pharmaceutical compositions, and activity in treating ischemias
FI940166A FI940166A0 (fi) 1992-05-14 1994-01-13 Uusia adenosiinijohdannaisia
NO940122A NO940122L (no) 1992-05-14 1994-01-13 Nye adenosinderivater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK92625A DK62592D0 (zh) 1992-05-14 1992-05-14

Publications (1)

Publication Number Publication Date
DK62592D0 true DK62592D0 (zh) 1992-05-14

Family

ID=8095700

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92625A DK62592D0 (zh) 1992-05-14 1992-05-14

Country Status (10)

Country Link
US (1) US5430027A (zh)
EP (1) EP0607367A1 (zh)
JP (1) JPH06508854A (zh)
AU (1) AU657415B2 (zh)
CA (1) CA2113546A1 (zh)
DK (1) DK62592D0 (zh)
FI (1) FI940166A0 (zh)
IL (1) IL105672A0 (zh)
NZ (1) NZ252109A (zh)
WO (1) WO1993023417A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62692D0 (zh) * 1992-05-14 1992-05-14 Novo Nordisk As
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
SE9401499D0 (sv) * 1994-05-02 1994-05-02 Item Dev Ab New method of treatment
EP0704215A3 (en) * 1994-06-02 1998-04-01 Takeda Chemical Industries, Ltd. Inhibitor of vascular permeability enhancer
US7348315B2 (en) 1995-03-23 2008-03-25 The University Of Connecticut Methods of treating heart failure with modified ATP, ADP and AMP compounds
US5712258A (en) * 1995-03-23 1998-01-27 The Trustees Of The University Of Pennsylvania Inotropic ADP and ATP analogues and their pharmaceutical compositions
WO1997033590A1 (en) * 1996-03-13 1997-09-18 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
AU2022597A (en) * 1996-03-13 1997-10-01 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
GB9610031D0 (en) * 1996-05-14 1996-07-17 Glaxo Group Ltd Chemical compounds
GB9723590D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB9813554D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
US7342003B2 (en) * 2001-10-25 2008-03-11 King Pharmaceuticals Research And Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
US7049303B2 (en) * 2001-11-07 2006-05-23 Medical Research Council Inhibition of viruses
US7094768B2 (en) * 2002-09-30 2006-08-22 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis C virus infection
NZ538457A (en) * 2002-09-30 2008-04-30 Genelabs Tech Inc Nucleoside derivatives for treating hepatitis C virus infection
WO2005033121A2 (en) * 2003-10-03 2005-04-14 King Pharmaceuticals Research & Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
US20100048501A1 (en) 2006-03-21 2010-02-25 Heinrich-Heine-Universitat Dusseldorf Phosphorylated A2A Receptor Agonists
DE102011005232A1 (de) 2011-03-08 2012-09-13 AristoCon GmbH & Co. KG Adenosin und seine Derivate zur Verwendung in der Schmerztherapie

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128629C (zh) * 1966-05-07
DE1670265A1 (de) * 1967-08-25 1971-01-28 Boehringer Mannheim Gmbh 2-Amino-Adenosinderivate und Verfahren zu deren Herstellung
BE768925A (fr) * 1970-06-30 1971-11-03 Takeda Chemical Industries Ltd Derives d'adenosine et procede de preparation
JPS4935635B1 (zh) * 1970-12-28 1974-09-25
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
EP0300144A3 (en) * 1984-04-18 1989-09-27 Whitby Research Incorporated N-6 alkyl substituted adenosine derivatives as cardiac vasodilators
JPH0696534B2 (ja) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 抗痴呆剤
US5155098A (en) * 1989-06-09 1992-10-13 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them
KR920703068A (ko) * 1989-09-15 1992-12-17 폴 레이킨드 신경변성 질환의 치료방법
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate

Also Published As

Publication number Publication date
FI940166A (fi) 1994-01-13
AU4061193A (en) 1993-12-13
CA2113546A1 (en) 1993-11-25
AU657415B2 (en) 1995-03-09
EP0607367A1 (en) 1994-07-27
IL105672A0 (en) 1993-09-22
FI940166A0 (fi) 1994-01-13
NZ252109A (en) 1996-05-28
WO1993023417A1 (en) 1993-11-25
US5430027A (en) 1995-07-04
JPH06508854A (ja) 1994-10-06

Similar Documents

Publication Publication Date Title
TW235251B (zh)
DK0553875T3 (zh)
DK0551248T3 (zh)
TW231307B (zh)
BR9304651A (zh)
DK62592D0 (zh)
BR9207065A (zh)
TW238393B (zh)
TW269645B (zh)
TW249854B (zh)
DK0559942T3 (zh)
DE9207553U1 (zh)
AU632452B2 (zh)
ECSDI920030S (zh)
ECSDI920070S (zh)
AU2098792A (zh)
GB9206217D0 (zh)
BRPI9204323A2 (zh)
AU2840792A (zh)
AU1729392A (zh)
CN3014437S (zh)
CN3013212S (zh)
CN3012489S (zh)
EP0559070A3 (zh)
CN3016198S (zh)

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment